1. Home
  2. TECX vs NPFD Comparison

TECX vs NPFD Comparison

Compare TECX & NPFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$29.27

Market Cap

554.1M

Sector

N/A

ML Signal

HOLD

Logo Nuveen Variable Rate Preferred & Income Fund

NPFD

Nuveen Variable Rate Preferred & Income Fund

HOLD

Current Price

$19.27

Market Cap

462.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECX
NPFD
Founded
2019
N/A
Country
United States
United States
Employees
60
N/A
Industry
Trusts Except Educational Religious and Charitable
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
554.1M
462.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
TECX
NPFD
Price
$29.27
$19.27
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$75.20
N/A
AVG Volume (30 Days)
189.7K
39.2K
Earning Date
05-07-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.39
$17.59
52 Week High
$35.99
$20.12

Technical Indicators

Market Signals
Indicator
TECX
NPFD
Relative Strength Index (RSI) 50.66 57.72
Support Level $28.31 $19.00
Resistance Level $31.88 $19.34
Average True Range (ATR) 1.53 0.17
MACD -0.17 0.04
Stochastic Oscillator 48.05 72.34

Price Performance

Historical Comparison
TECX
NPFD

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About NPFD Nuveen Variable Rate Preferred & Income Fund

Nuveen Variable Rate Preferred&Income is a diversified, closed-end management investment company. Its investment objective is to provide a high level of current income and total return. The fund invests a majority of its assets in variable-rate preferred securities and other variable-rate income-producing securities. The rest of its investments can be made in contingent capital securities or contingent convertible securities, convertible securities, corporate debt securities, U.S. government securities, residential and commercial mortgage-backed securities, fixed-rate preferred securities, senior loans and loan participations and assignments, sovereign debt instruments, debt securities issued by supranational agencies, and/or taxable and tax-exempt municipal bonds.

Share on Social Networks: